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Objective: The purpose of this study was to evaluate the treatment of patients 
with infected implantable cardioverter-defibrillator systems. Methods: Retro- 
spective analysis was done of the cases of 21 patients treated for implantable 
cardioverter-defibrillator infection during an ll-year period. Results: Of 723 
cardioverter-defibrillator implantations (550 primary implants, 173 replace- 
ments), nine (1.2%) were complicated by early postoperative d vice-related 
infections. Late infections developed in two patients 19 and 22 months, 
respectively, after implantation. Ten other patients were transferred to our 
institution for treatment of cardioverter-defibrillator infection. The time from 
implantation to overt infection was 2.2 _+ 1.3 months, excluding the two late 
infections. The responsible organisms were Staphy~:occus aureus (9), Staphy- 
lococcus epidermidis (6), Streptococcus hemolyticus (1), gram-negative bacteria 
(3), Candida albicans (1), and Corynebacterium (1). ~Ml patients were treated 
with intravenous antibiotic drngs. Total system removal was done in 15 
patients and partial removal in 2; in 4, the cardioverter-defibrillator system 
was not explanted. There were no perioperative deaths. A new implantable 
cardioverter-defibrillator system was reimplanted in 7 patients after 2 to 6 
weeks of antibiotic therapy. Ten patients were treated without reimplantation 
(2 arrhythmia operation, 8 antiarrhythmic drngs). Four patients (3 patients 
without explantation and 1 with partial system removal) were treated with 
maintenance long-term antibiotic therapy. During a mean follow-up of 21 - 
2.8 months, no patient had clinical recurrence of in ection. One patient treated 
with antiarrhythmic drngs without system reimplantation died suddenly. 
Conclusions: Infections that involve implantable cardioverter-defibrillator sys- 
tems can be safely managed by removing the entire system with reimplantation 
after intravenous antibiotic therapy. In selected patients in whom the risk for 
system explantation is high and anticipated life expectancy is short, long-term 
antibiotic therapy to suppress low-virulence infections may represent an 
acceptable alternative. (J Thorac Cardiovasc Surg 1997;113:121-9) 
T he development of the automatic implantable cardioverter-defibrillator (ICD) in the early 
1980s represented a major advance in the treatment 
of life-threatening ventricular arrhythmias. 1 The 
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treatment of patients who receive these devices may 
pose several difficult clinical problems, and of these 
the treatment of ICD-system infection remains one 
of the most important. The recent availability of 
nonthoracotomy lead systems, coupled with gener- 
ators capable of delivering biphasic shocks, has 
simplified device implantation substantially. Be- 
cause an increasing number of device implantations 
is likely to be done by nonsurgically trained cardiac 
electrophysiologists 2, 3 rather than with the current 
combined surgeon/electrophysiologist approach, the 
prevalence of device infection may transiently 
change. It is timely therefore to review the preva- 
lence and treatment of ICD infections not only as a 
guide for management, but also to put in perspective 
the standards that implanting cardiac electrophysi- 
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Table I. Patient clinical characteristics 
Age and L VEF Primary 
sex Disease Arrhythmic (%) DM Operation implant 
Group A 
1. 45F RHD/MI  SMVT 20 - - -  Yes (rev) 
2. 71M CAD SMVT 40 + CABG Yes 
3. 76M CAD CA 20 - - -  Yes 
4. 69M CAD VF  43 - CABG No 
5. 57M CAD VF  34 - CABG Yes 
6. 79M CAD SMVT 35 - - -  Yes 
7. 58M CAD SMVT 43 - CABG Yes 
8. 33M DCM VF  73 - - -  Yes  
9. 68M CAD SMVT 18 - CABG Yes 
10. 83M CAD SMVT 23 - CABG Yes 
11. 62M DCM VF  25 - - -  No  
Group B 
12. 47M VHD VF  52 - AVR Yes (rev) 
13. 46M CAD SMVT 28 - - -  Yes  
14. 67F VHD VF  34 - MVR Yes (rev) 
15. 74M CAD SMVT 43 + - -  Yes  
16. 60M CAD SMVT 30 + - -  Yes 
17. 69M CAD CA 45 - CABG Yes 
18. 69M CAD VF  25 - CABG Yes (rev) 
19. 56M CAD VF  35 + - -  Yes 
20. 76M CAD CA/SMVT 36 - - -  Yes 
21. 49M CAD CA/SMVT 23 + CABG Yes 
AVR, Aortic valve replacement; CA, cardiac arrest; CABG, coronary artery bypass grafting; CAD, coronary artely disease; DM, diabetes mellitus; DCM, 
dilated cardiomyopathy; LVEF, left ventricular ejection fraction; MI, myocardial infarction; MVR, mitral valve replacement; Rev, system revised; RHD, 
rheumatic beart disease; SMVT, sustained monomorphic ventricular tachycardia; VF, ventricular fibrillation; VHD, valvular heart disease. 
ologists must set for themselves. This study exam- 
ines retrospectively the experience of treating de- 
vice-related infection in a single center with an 
ll-year experience of ICD implantation with a joint 
surgeon/electrophysiologist approach. 
Methods 
Patient population. The study population com- 
prised 21 patients with infected ICD systems treated 
at the Massachusetts General Hospital between 
June 1983 and May 1994. These 21 patients were 
divided into two groups: group A comprised 11 
patients with infected ICD systems whose primary 
implantation or most recent generator change was 
done at the Massachusetts General Hospital, and 
group B comprised 10 patients in whom the primaly 
implantation was done at an outside institution but 
who were transferred to our institution for treat- 
ment of device-related infection. 
Group A patients were drawn from the 556 
patients who underwent implantation of723 ICDs at 
our institution for the treatment of spontaneous 
sustained ventriculär tachycardia or fibrillation or of 
inducible, sustained ventricular tachycardia n pa- 
tients with organic heart disease with syncope and 
nonsustained ventricular tachycardia. Five hundred 
fifty procedures were primary implantations and 173 
were generator changes. Among the 550 primary 
implantations, 354 patients had an attempted non- 
thoracotomy insertion. Among these 196 patients, a
compl~te nonthoracotomy lead system with or with- 
out a subcutaneous patch could be implanted in 156 
(80%), whereas 40 required thoracotomy and a 
combination of transvenous defibrillation coil elec- 
trodes with epicardial patch electrodes. 
Infection was suspected when there were local 
symptoms such as erythema, tenderness, swelling, or 
purulent drainage from the thoracic or abdominal 
site. When there was swelling and erythema without 
spontaneous drainage, culture material was ob- 
tained by aspiration from the ICD pocket. In all 
cases, Gram's stains and aerobic and anaerobic 
bacterial and fungal cultures were obtained. A pos- 
itive culture was required to make the diagnosis of 
ICD infection, and no patient underwent device 
explantation without a positive culture of blood, 
exudate, or aspirate. The clinical characteristics of 
the two groups are summarized in Table I. 
For those patients in whom the ICD was im- 
planted at our institution, the implantation proce- 
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Fig. 1. Timing of ICD infection as function of ICD implant number (Xaxis) and year of implantation. First 
implant of each year is depicted by hatched vertical lines, that is, number of implants until next vertical line 
equals implants for that year. Triangles represent individual infections at our institution 
dure evolved with changing technology. During 
the initial phase encompassing the early years, all 
devices were implanted by thoracotomy with extra- 
pericardial or epicardial placement of defibrilla- 
tion patch electrodes and transvenous bipolar 
rate-sensing leads. An additional superior vena 
caval coil electrode was implanted transvenously 
in those patients who received either a single left 
ventricular patch electrode or a two-patch epicar- 
dial system with high defibrillation thresholds. 
ICD implantation was done as a two-stage proce- 
dure. The rate-sensing lead and the superior vena 
caval coil electrode were implanted in the pace- 
maker laboratory with closure of the infraclavic- 
ular pocket. The epicardial patch electrode was 
implanted later on the same day in the operating 
room with simultaneous tunneling of the sensing 
electrode from the infraclavicular to the abdomi- 
nal pocket. With the advent of nonthoracotomy 
lead systems, implantation remained a two-step 
procedure. The transvenous defibrillation leads 
were first implanted in the pacemaker laboratory 
with the use of local anesthesia. The pulse gener- 
ator unit and any additional subcutaneous or 
epicardial patch electrodes, as dictated by results 
of defibrillation threshold testing, were implanted 
later on the same day in the operating room. 
Routine intravenous antibiotic prophylaxis was 
used in all patients for both primary implantation 
and generator change. Early in the experience, 
Table II. Nonthoracotomy approach infections 
Infections 
Total No. 
of patients No. % 
Group A (n = 3) 
Atternpted NTL 196 3 1.5 
Successful NTL 156 2 1.3 
Lead only 67 2 
SQ patch 89 0 
Epicardial patch 40 1 2.5 
Group B (n = 1) 
One patient with a single 
transvenous lead and SQ patch 
NTL, Nonthoracotomy lead system; SQ, subcutaneous. 
vancomycin (500 mg every 6 hours) alone was 
given before operation and for 48 to 72 hours 
after operation. Subsequently intravenous cefazo- 
lin (1 gm every 8 hours) was added to the regimen, 
to broaden the spectrum of antibiotic prophylaxis 
on the one hand and to reinforce prophylaxis 
against he Staphylococcus species on the other. 
All patients were followed up at 2- to 3-month 
intervals either at the ICD clinic of the Massachu- 
setts General Hospital (176 patients) or by their 
referring cardiologist. 
Results 
Prevalence of infection 
Group A. Eleven of 723 implantation procedures 
at the Massachusetts General Hospital (1.5%) were 
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Fig. 2. Time from implantation or revision to ICD infection. 
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Table III. Infecting organisms 
Blood Duration of 
Patient Organism cultures Cons. Rx lntrathoracic Abx Rx (wk) Follow-up (mo) 
1. Escherichia coli Neg No No 4 30 
MorganeUa 
2. Proteus vulgaris Neg No No 2.5 51 
Enterobacter cloacae 
3. Staph. epidermidis Neg No No 4 5 
4. Strep. B group Pos Yes Unknown Long-term 32 
5. Staph. aureus Pos No No 2.5 48 
6. Staph. aureus Neg RV lead in situ Yes Long-term 6 
7. Staph. aureus Pos Failed Yes 4 54 
8. Staph. epidermidis Neg No No 3 41 
9. Klebsiella pneumoniae Neg Yes Unknown 2 5 
10. Staph. aureus Pos No No 4 5 
11. Staph. epidermidis Neg Yes Unknown Long-term 1 
12. Staph. epidermidis Neg Failed Yes 4 30 
13. Staph. aureus Pos Failed Yes 6 24 
14. Staph. aureus Neg No Yes 4 14 
15. Staph. epidermidis Pos No No 2 26 
16. Staph. aureus Neg No Yes 6 14 
17. Staph. aureus Pos Failed Yes 4 12 
18. Candida albicans Neg Yes Unknown Long-term 11 
19. Staph. aureus Neg Failed Yes 4 7 
20. Corynebacterium Neg No No 2 5 
21. Staph. epidermidis Neg Failed Yes 6 28 
Abx Rx, Antibiotic treatment; Cons. Rx, attempted conservative tr atment; Neg, negative; Pos, positive; RV, right ventricular; Staph., Staphylococcus," Strep., 
Streptococcus. 
complicated by device infection. Nine of these in- 
fections occurred within 6 months of the implanta- 
tion procedure giving an early postprocedure infec- 
tion rate of 1.2%; there was an additional 0.3% late 
infection rate (2 patients at 19 and 22 months, 
respectively). One hundred eighty-seven patients 
had more than one generator implantation, giving a 
per-patient infection rate of 2.0%. 
The infection rate was not significantly different 
for primary implants versus generator replacements: 
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Fig. 3. Overall management of infection. (1), Patient who had also received long-term antibiotic therapy; 
(1) *, patient who received short-term antibiotic therapy only. 
1.6% (9/550) and 1.2% (2/173), respectively. Like- 
wise, the infection rate in those 196 patients who 
underwent an attempted nonthoracotomy s stem 
implantation was no different from the rate in those 
who underwent a planned thoracotomy implanta- 
tion (Table II). Fig. 1 shows the prevalence of 
infection as a function of time and implantation 
experience. The prevalence of infection in the first 
100 patients from 1983 to 1988 was only 1%. Over 
the ensuing years and experience, the prevalence of 
infection has remained relatively constant. 
Group B. Because these patients were drawn 
from an unknown overall population from multiple 
institutions, no comment can be made on the prev- 
alence of infection in this group. 
Presentation. The time from implantation to overt 
infection was 2.2 _+ 1.3 months, excluding the two late 
(19 months and 22 months) infections (Fig. 2). The 
most common presenting site was the generator 
pocket in 13 patients, infraclavicular wound in 2, 
subcutaneous patch in 1, epicardial patch in 1, and 
sternal wound in 1. Overall 18 (86%) patients had 
culture evidence of ICD generator pocket infection, 
even when this was not the site of presentation; only 10 
patients (48%) had systemic symptoms of infection 
with positive blood cultures in 7 (Table III). Septice- 
mia, including septic shock in a patient receiving 
steroids, without initial signs of local infection, was the 
primary presentation i  3 (14%) of the 21 patients. 
Organisms. The organisms responsible for infec- 
tion are listed in Table III. The majority of infec- 
tions were caused by Staphylococcus (70%) and 
occurred early after implantation (Fig. 2). In 2 
patients, however, late S. aureus infection developed 
19 and 22 months after implantation, respectively. 
Five of the 9 patients who had S. aureus infection 
had positive blood cultures. 
Three patients had gram-negative infection, and 
in two of these more than one organism was isolated 
(Escherichia coli and Morganella species, Proteus 
vulgaris, and Enterobacter cloacae). In three patients 
a potential source of primary infection other than 
the ICD was provided by staphylococcal pneumonia 
(2) and a gram-negative urinary tract infection (1). 
Management. The overall management s rategy 
in the 21 patients is shown in Fig. 3. 
System removal. During the initial experience 
with management of ICD infections, attempts to 
treat conservatively two patients with S. aureus 
infection were unsuccessful. Subsequently the con- 
servative approach in patients with S. aureus infec- 
tions was abandoned, and all such patients were 
subsequently treated aggressively with high-dose 
intravenous antibiotics and complete system re- 
moval when feasible (Fig. 4). The one exception was 
a 78-year-old frail patient who was judged a poor 
risk candidate for cardiopulmonary bypass to re- 
move the right ventricular lead, which could not be 
extracted via the infraclavicular wound. This lead 
was therefore left in and all other hardware was 
removed. Of those patients transferred from other 
institutions, an initial conservative approach had 
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Fig. 4. Numbers of patients who underwent complete or partial system removal and responsible 
organisms. 
been attempted unsuccessfully in four patients be- 
fore transfer. 
Among the 17 patients in whom complete system 
removal was done, the initial implantation had been 
by median sternotomy (6), left lateral thoracotomy 
(4), subxiphoid (4), and nonthoracotomy approaches 
(3) (Table IV). Removal of these systems involved 
median sternotomy (4), bilateral thoracotomies (4), 
and unilateral thoracotomy (6). Four patients with 
transvenous defibrillation electrodes had infections: 
two with the single CPI Endotak (Cardiac Pacemak- 
ers, Inc., St. Paul, Minn.) lead and two with the 
dual-lead Medtronic Transvene system (Medtronic, 
Inc., Minneapolis, Minn.), which has an active fixation 
screw-in right ventricular electrode. Three of these 
infections occurred early after implantation (-<6 
months), and the transvenous leads with or without he 
subcutaneous patch electrodes were easily removed. 
The screw-in right ventricular lead could not be ex- 
tracted in one patient in whom late infection devel- 
oped and was therefore cut in the infraclavicular 
region and left in situ as mentioned previously. 
Two patients had prosthetic mechanical valves 
and two patients had dual-chamber permanent 
pacemakers at the time the ICD system infection 
became clinically apparent (Table I). Despite evi- 
dence of intrathoracic infection in two patients and 
septic shock in a third patient with a permanent 
pacemaker, the prosthetic valves and permanent 
pacemakers were not removed at the time of ICD 
explant. This decision was aided by transesophageal 
echocardiography findings, which did not show any 
evidence of vegetations or a paraprosthetic valve 
leak in the patient with an aortic valve prosthesis. 
Late reinfection did not occur in these four patients. 
All patients received high-dose intravenous anti- 
biotic drugs for 2 to 6 weeks guided by the sensitivity 
of the organism. The duration of treatment was 
influenced by the time from diagnosis to system 
removal and the virulence of the infection. When 
complete system removal was achieved, long-term 
antibiotic therapy was never necessary. 
Long-term antibiotie therapy without system re- 
moval. In addition to the single patient described 
herein who had S. aureus infection and partial 
system removal, four other patients with relatively 
low-virulence infeetions or poor clinical status were 
treated conservatively without ICD system removal. 
All were treated with high-dose intravenous antibi- 
otics, and four patients ubsequently received main- 
tenance long-term oral antibiotic therapy. The re- 
sponsible organisms in these four patients were 
Staphylococcus epidermidis, Candida albicans, group B 
Streptococcus hemolyticus, and Klebsiella pneumonia. 
System reimplantation. Of the 17 patients who 
underwent system removal, 7 underwent new system 
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Table 1V. ICD infection: surgical treatment strategy 
In#iM Previous Patches (No.) and Alternative 
implant revision RSL transvenous leads Removal Reimplantation therapy 
Group A 
1. LL thorac. 
2. Med. stern. 
3. NTL only 
4. Med. stern. 
5. Med. stern. 
6. LL thorac. 
7. Med. stern. 
8. LL thorac. 
9. Med. stern. 
10. NTL only 
11. Subx 
Group B 
12. Med. stern. 
13. Subx 
14. Med. stern. 
15. Subx 
16. Subx 
17. Med. stern. 
18. Med. stern. 
19. Subx 
20. NTL 
21. Med. stern. 
Yes Endo Epi (2) LL thorac. No 
No Epi Epi (2) Bilat. thorac. No 
No Endo Endotak system only NTL NTL 
No Endo Epi (1) + SVC coil N/A N/A 
No Epi Epi (1) + SVC coil LL thorac. N/A 
No Endo Epi (1) + Transvene system LL thorac. + Subx N/A 
No Endo Epi (2) Bilat. thorac. N/A 
No Endo Epi (2) LL thorac. Subx 
No Endo Epi (2) N/A N/A 
No Endo Transvene system only NTL N/A 
No Endo Epi (1) + SVC coil N/A N/A 
Aneurysmect. 
Amiodarone 
Amiodarone 
Amiodarone 
BB + class I drugs 
Class I drugs 
Yes Epi Epi (2) + SVC coil LL thorac. NTL + Subx 
No Endo Epi (1) + SVC coil Med. stern. No Aneurysmect. 
Yes Epi Epi (3) Bilat. thorac. N/A Class I drugs 
No Epi Epi (2) Subx + Med. stern. NTL + LL thorac. 
No Epi Epi (2) Med. stern. NTL 
No Epi Epi (2) Bilat. thorac. (2) N/A Patches only 
Yes Epi Epi (4) + SVC coil N/A N/A 
No Epi Epi (2) Med. stern. N/A Sotalol 
No Endo SQ + Endotak system NTL NTL 
No Epi Epi (2) R thorae. NTL + epi (1) 
Aneurysmect, Aneurysmectomy; BB, 
nonthoracotomy lead system; N/A, 
thoracotomy. 
beta blocker; bilat, bilateral; endo, endocardial; epi, epicardial; LL, ieft lateral; med. stem., median sternotomy; NTL, 
not applicable; RSL, rate-sensing lead; SQ, subcutaneous; Subx, subxiphoid; SVC, superior vena caval; Thorac., 
reimplantation after 2 to 6 weeks of high-dose 
intravenous antibiotic therapy. Whether system re- 
implantation was done during the same hospitaliza- 
tion was determined by the seriousness of the pre- 
senting arrhythmia, the ability to control or modify 
the arrhythmia with antiarrhythmic drug therapy, 
and the state of wound healing. Four patients had 
the system reimplanted uring the same hospitaliza- 
tion. Three other patients were discharged home 
receiving antiarrhythmic therapy and were readmit- 
ted to the hospital after 3 to 9 months for system 
reimplantation. Three of the seven patients received 
complete nonthoracotomy lead systems. Three pa- 
tients required a new epicardial patch electrode: in 
two patients who had previously undergone left 
lateral thoracotomy, the subxiphoid approach was 
used, whereas in one patient whose initial system 
had been implanted by a subxiphoid approach, a left 
lateral thoracotomy was done. In the final patient a 
previous epicardial patch electrode that had not 
been removed was used again. 
System removal without reimplantation. Ten pa- 
tients underwent system removal without reimplanta- 
tion. These patients received 2 to 6 weeks of antibiotic 
therapy. Two patients underwent map-guided left ven- 
tricular aneurysmectomy. At postoperative electro- 
physiologic study, these two patients had no inducible 
ventricular arrhythmia and an ICD was not reim- 
planted. Another patient did not undergo system 
replacement, because he had no inducible ventricular 
arrhythmia after coronary artery bypass grafting. 
Seven patients either refused or were unfit to undergo 
system reimplantation after protracted illness. Of 
these seven, four were treated with long-term class III 
antiarrthymic drugs (3 amiodarone, 1 sotalol) and 
three patients with class I antiarrhythmic drugs. 
Follow-up. There was no in-hospital mortality. 
During a mean follow-up of 23.5 months (range 5 to 
54) no patient treated with complete or partial system 
removal had recurrent infection. Among the four 
patients treated with short-term followed by long-term 
antibiotic therapy without system removal, none had a 
clinical recurrence of infection during a mean fol- 
low-up of 12.3 months (range 1 to 32). 
Of the 21 patients with ICD infection, four pa- 
tients died, three of progressive heart failure. One 
patient died suddenly 14 months after system re- 
moral while being treated with a class I antiarrhyth- 
mic drug. Among 556 group A patients follow-up 
data were available in 478 (86%). The mean fol- 
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low-up period was 41 months. Of the 478 patients, 
381 (80%) were alive at the end of the follow-up 
period, whereas 97 (20%) had died. Twelve patients 
had undergone cardiac transplantation with explan- 
tation of the ICD at the time of transplantation. 
Discussion 
Previous studies of patients with ICDs have re- 
ported an infection rate between 2% and 11%. 4-8 
Recent reports of the use of nonthoracotomy leads 
suggest a lower in¢idence of infeetion with these 
systems,& 9 with one large multicenter study with 
short-term follow-up reporting an incidence as low 
as 1.2%. 1° Our results from a single institution with 
a large implanting experien¢e show that with use of 
a combined cardia¢ electrophysiologist/cardiac sur- 
gical approa¢h, the ineidence of deviee-related in- 
fection ¢an be as low as 1.5%. The infection rate is 
no different for primary implantations versus gener- 
ator replacements and no different for eonfigura- 
tions that use transvenous defibrillation coils. 
There has been considerable debate as to the 
optimal mode of treatment for infe¢ted ICD sys- 
tems: some authors suggest immediate system re- 
moval with reimplantation of the same generator 
after debridement, followed by continuous irrigation 
of the generator pocket with antibiotic solution. 11 
Our initial unsuccessful attempts to treat S. aureus 
infe¢tions conservatively led to a more radical policy 
of complete ICD system explantation onee infection 
with this organism had been diagnose& This ap- 
proach has been extended to infections with poten- 
tially less virulent organisms. In support of this more 
aggressive approach, several of the patients trans- 
ferred to our institution had unsuc¢essful attempts 
at infection control either with generator emoval 
alone or partial system removal. Wunderly and 
colleagues 12also reported similar disappointing re- 
sults with four out of five failures when attempts 
were made to treat infection without complete 
system removal. Once the infection had finally been 
eradicated, these investigators eimplanted the orig- 
inal generator, which had been resterilized, without 
further problems. Although the North American 
Society of Pacing and Electrophysiology has pub- 
lished guidelines for the reuse of permanent pace- 
makers, the safety of reusing ICD generators in a 
similar way has not been established. 
Diagnosis of pocket infection can be made by 
direct inspection and cultures of wound drainage or 
aspiration of pocket fluid. Diagnosis of whether the 
infection involves the defibrillating or sensing elec- 
trodes and extends intrathoracically is more difficult. 
As a principle we assume the presence of lead/in- 
trathoracic infection when S. aureus is the infecting 
organism. Kelly and associates 13 have described the 
value of gallium-labeled leukocyte scans in the 
demonstration of intrathoracic spread of device-re- 
lated infection. They used this technique in three 
patients with S. aureus infection to demonstrate both 
generator pocket and intrathoracic infection. How- 
ever, neither the sensitivity nor specificity of this 
technique has been fully defined for patients with ICD 
infection. 
In contrast to our relatively radical approach, 
other authors have suggested a more conservative 
approach to ICD infection. Among 12 cases of 
infection treated by Watkins and Taylor 14 at Johns 
Hopkins, these authors judged that the infection was 
limited to the pocket alone in six patients. They 
removed the generator, treated with parenteral an- 
tibiotics, then reimplanted the generator on the 
opposite side and used the original lead system. 
Although in general we favor a radical approach 
to device infection, the patient's overall clinical 
condition may prohibit this approach. We have 
successfully treated four patients with lower viru- 
lence infection (for example, Candida albicans) with 
long-term oral antibiotic therapy. It is unlikely that 
these infections have been eradicated; they are 
probably chronically suppressed as evidenced by the 
patient with Streptococcus hemolyticus in whom fe- 
ver immediately redeveloped once penicillin therapy 
was stopped. In such patients the risk of system 
removal taust be balanced against he risk of long- 
term antibiotic therapy or continuing infection with 
the risk of subacute bacterial endocarditis or other 
uncontrollable sepsis, as well as against he antici- 
pated cardiac natural history. 
Because the success rate of complete nonthora- 
cotomy ICD systems has now risen from 70% to 
75% to greater than 90% with the use of generators 
capable of delivering biphasic shocks, the issue of 
defibrillator replacement after successful control of 
infection will be less complex. In our study, a small 
number of patients had nonthoracotomy lead sys- 
tems removed because of infection. When this oc- 
curs early, as is the rule, electrode removal is 
relatively simple. For system infection that develops 
rauch later, lead extraction can prove more prob- 
lematic. Although it is generally believed that late 
extraction of screw-in electrode systems can be 
achieved more easily than it can with tined fixation 
systems, it is likely that removal of either system late 
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after implantation (>18 months) will be diflicult. 
After the development of the Cook extraction sys- 
tem, the necessity for thoracotomy for late removal 
of infected pacemaker leads has been reduced to 
less than 10%. 15'16 Whether these systems will 
prove equally effective and safe for the removal of 
the currently larger transvenous defibrillation elec- 
trodes remains to be established, though prelimi- 
nary results appear encouraging. ~~ 
The decision regarding device reimplantation af- 
ter a prolonged period of antibiotic therapy can 
often be ditficult both for the patient and physician. 
It may be argued that the actuarial survival of 95 (of 
a total of 1,896) recipients in the Bilitch Registry 
who had the systems removed (33 because of infec- 
tion) was the same as that for those who never had 
the systems explanted, is In our series one patient 
had an episode of in-hospital cardiac arrest after 
ICD removal, and a second patient who refused 
reimplantation died suddenly. Until the wider issue 
of the influence of ICD versus antiarrhythmic drug 
therapy on overall survival is resolved, we currently 
recommend efibrillator reimplantation, with use of 
a nonthoracotomy approach when feasible, unless 
curative map-guided endocardial resection has been 
done without inducible arrhythmias after operation. 
We routinely use antibiotic prophylaxis for all pri- 
mary ICD implantations and generator changes. 
Whether this reduces the incidence of infection is 
unproved. The use of prophylactic antibiotics for pa- 
tients undergoing other surgical procedures or dental 
procedures is even less clearly defined, though we 
offen recommend antibiotic prophylaxis for such pro- 
cedures for 3 months after primary implantation. 
Limitations. In 10 patients with ICD infection 
referred to our institution, a conservative approach 
had already failed in 4. Therefore these referred 
patients may be a selected group either because of 
infections refractory to conservative management or 
because of poor medical condition. Thus, consider- 
ing all ICD infections in general, the effectiveness of 
conservative management may be better than sug- 
gested by our experience. Furthermore, although 
this study represents a single institution's experi- 
ence, it is a retrospective study that examines a 
single mode of clinical practice without any random- 
ization to different modes of management. We 
cannot, therefore, claim that our approach to treat- 
ment is superior to other methods. However, given 
this approach the in-hospital mortality from infec- 
tion in this series was zero, and the short-term 
follow-up was favorable. 
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